Update on Cardiac Science's Purchase of Artema

(Irvine, CA, USA) has announced that it expects to complete its planned acquisition of Artema Medical AB of Stockholm (Sweden) in early June.

Cardiac Science develops and markets external cardiac defibrillator devices and proprietary software that monitors and automatically treats patients who suffer life-threatening heart rhythms. Artema develops and markets bedside and portable multi-parameter patient monitors and defibrillator devices. Cardiac Science believes that the integration of its technology into Artema's patient monitors will provide a unique product capability advantage.

"Although the acquisition of Artema is a relatively lengthy and complex process due to the interaction of various regulatory requirements in Sweden and the United States, we are working aggressively to conclude this transaction as quickly as possible,” said Roderick de Greef, executive vice president and chief financial officer of Cardiac Science.



Related Links:
Cardiac Science Inc.
Artema Medical